The New Edge in Pharma: Smarter Physician Activation for Complex Therapies

“Just by stacking data, you get inconsistencies… missing data, holes, and biases that need to be accounted for to produce actionable insights.”

In today’s competitive launch environment, timing isn’t everything, it’s the edge. With tighter budgets, increasingly restricted physician access, and a rising number of complex therapies hitting the market, commercial teams are being asked to do more with less.

Yet many are still relying on fragmented or delayed data, disconnected engagement tactics, and traditional field models to reach the physicians who matter most. The result? Missed opportunities, slower uptake, and patients who never make it to treatment. Diaceutics’ DXRX Signal and Physician Engage are designed to meet this challenge head-on, enabling smarter, faster activation of the right physicians at the moment of relevance.

The Access Crisis: Why Traditional Models Are Breaking

Physician access has changed dramatically:

• Over 60% of U.S. physicians now restrict or limit rep access with oncology and specialty care among the most access-constrained.(Source: (AMA, "Physician Practice Benchmark Survey," 2023).
• Nearly half of HCP engagement now happens through non-personal channels which are increasingly crowded, commoditized, and often ignored (Source: Veeva Systems, "2023 Trends in HCP Omnichannel Engagement Report," 2023)

In this environment, even the best field team can’t consistently show up at the right time with the right message. To succeed, brands need a new model: one that activates physicians at the moment of relevance, not the end of a campaign calendar.

Precision Engagement Starts With Smarter Data

As Jordan Clark, Chief Data Officer at Diaceutics, shared during our recent webinar:

“Just by stacking data, you get inconsistencies… missing data, holes, and biases that need to be accounted for to produce actionable insights.”

Too often, teams assume that combining claims, EHR, lab, genomic, and SDOH data will create clarity. But without standardization, timeline alignment, and bias correction, it simply increases noise.

Diaceutics’ multimodal AI engine integrates lab, genomic, claims, and EHR data—delivering real-time, actionable insights that outperform traditional targeting.

When Physician Activation Gets Smarter, Results Follow

Across therapy areas, brands using structured physician signals and targeted activation strategies are seeing measurable commercial outcomes.

Here’s what smarter engagement looks like in action:

• Precision Oncology
  A top 10 pharma brand saw a 35.6% increase in new patient starts within six months by activating physicians through patient-specific signal triggers.
• Cardiovascular Therapy
  Mapping care teams using multimodal data led to a 19% increase in actionable HCP targets, improving engagement across roles beyond the prescriber.

• Rare Disease
  A genomic-targeted program identified 88 eligible patients compared to just 8 found via traditional claims-based targeting.
• Hematologic Oncology
  One biopharma company grew market share by 8% in 12 months by delivering education at the point of clinical decision—not weeks later.
  
  

From Information to Activation: A Paradigm Shift

As Gunjan Aggarwal noted in the same webinar:

“We’re at an inflection point where data no longer follows decisions—it drives them.”

The implication is clear: what you know matters less than when and how you act on it. Engagement must move beyond static campaigns and field force timing to dynamic, data-informed decision points.

What This Means for You

If your therapy requires precise eligibility, cross-specialty coordination, or is at risk of underutilization due to timing gaps this model applies to you.

Whether you’re launching a new therapy or reinvigorating an existing brand, DXRX Signal and Physician Engage offer the tools to activate smarter, faster, and more effectively.